Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 3.206 | 8.77e-20 | 2.72e-06 | 8.57e-05 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
[ MED12 ] | 9968 | 14 | -2.465 | 3.206 | 65 | Yes | - |
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
APLP2 | 334 | 12 | -2.732 | 3.206 | 35 | Yes | Yes |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
APLP2 | 334 | MED12 | 9968 | pp | -- | int.I2D: MINT; int.Mint: MI:0407(direct interaction) |
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HCFC1 | 3054 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
MED12 | 9968 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006366 | transcription from RNA polymerase II promoter | 2.29e-05 | 3.31e-01 | 4.298 | 4 | 30 | 419 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.06e-04 | 1.00e+00 | 6.964 | 2 | 8 | 33 |
GO:0016592 | mediator complex | 1.19e-04 | 1.00e+00 | 6.879 | 2 | 10 | 35 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0005654 | nucleoplasm | 9.17e-04 | 1.00e+00 | 2.929 | 4 | 64 | 1082 |
GO:0019046 | release from viral latency | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0014044 | Schwann cell development | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0070461 | SAGA-type complex | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 2 | 5 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0016607 | nuclear speck | 2.85e-03 | 1.00e+00 | 4.582 | 2 | 12 | 172 |
GO:0070688 | MLL5-L complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0007617 | mating behavior | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 5 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 4 | 9 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.83e-03 | 1.00e+00 | 2.970 | 3 | 41 | 789 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0008380 | RNA splicing | 4.96e-03 | 1.00e+00 | 4.176 | 2 | 22 | 228 |
GO:0005634 | nucleus | 5.08e-03 | 1.00e+00 | 1.439 | 6 | 159 | 4559 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0003713 | transcription coactivator activity | 5.35e-03 | 1.00e+00 | 4.120 | 2 | 24 | 237 |
GO:0006878 | cellular copper ion homeostasis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0005685 | U1 snRNP | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0001967 | suckling behavior | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 6 | 14 |
GO:0043981 | histone H4-K5 acetylation | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 5 | 15 |
GO:0042809 | vitamin D receptor binding | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 6 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 3 | 15 |
GO:0006376 | mRNA splice site selection | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 5 | 15 |
GO:0043274 | phospholipase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 16 |
GO:0043984 | histone H4-K16 acetylation | 9.19e-03 | 1.00e+00 | 6.761 | 1 | 5 | 19 |
GO:0014003 | oligodendrocyte development | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 5 | 20 |
GO:0043393 | regulation of protein binding | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 20 |
GO:0003682 | chromatin binding | 9.98e-03 | 1.00e+00 | 3.656 | 2 | 19 | 327 |
GO:0000123 | histone acetyltransferase complex | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 6 | 21 |
GO:0045787 | positive regulation of cell cycle | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 4 | 22 |
GO:0044822 | poly(A) RNA binding | 1.10e-02 | 1.00e+00 | 2.549 | 3 | 50 | 1056 |
GO:0046966 | thyroid hormone receptor binding | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 6 | 26 |
GO:0071339 | MLL1 complex | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 6 | 27 |
GO:0030901 | midbrain development | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0003677 | DNA binding | 1.62e-02 | 1.00e+00 | 2.343 | 3 | 49 | 1218 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 4 | 35 |
GO:0035019 | somatic stem cell maintenance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 6 | 40 |
GO:0050885 | neuromuscular process controlling balance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 40 |
GO:0030521 | androgen receptor signaling pathway | 1.97e-02 | 1.00e+00 | 5.651 | 1 | 5 | 41 |
GO:0031124 | mRNA 3'-end processing | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 42 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.07e-02 | 1.00e+00 | 5.582 | 1 | 7 | 43 |
GO:0042802 | identical protein binding | 2.11e-02 | 1.00e+00 | 3.090 | 2 | 19 | 484 |
GO:0003712 | transcription cofactor activity | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 8 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 45 |
GO:0019827 | stem cell maintenance | 2.26e-02 | 1.00e+00 | 5.454 | 1 | 7 | 47 |
GO:0030900 | forebrain development | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 1 | 49 |
GO:0005515 | protein binding | 2.38e-02 | 1.00e+00 | 1.037 | 6 | 198 | 6024 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 5 | 53 |
GO:0008203 | cholesterol metabolic process | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 2 | 57 |
GO:0008013 | beta-catenin binding | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 4 | 61 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 3 | 63 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0007626 | locomotory behavior | 3.40e-02 | 1.00e+00 | 4.859 | 1 | 2 | 71 |
GO:0003729 | mRNA binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0001843 | neural tube closure | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 2 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 75 |
GO:0016020 | membrane | 3.85e-02 | 1.00e+00 | 1.879 | 3 | 46 | 1681 |
GO:0010467 | gene expression | 3.86e-02 | 1.00e+00 | 2.623 | 2 | 45 | 669 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.19e-02 | 1.00e+00 | 2.560 | 2 | 39 | 699 |
GO:0050821 | protein stabilization | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 3 | 88 |
GO:0010951 | negative regulation of endopeptidase activity | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 6 | 104 |
GO:0006325 | chromatin organization | 5.59e-02 | 1.00e+00 | 4.126 | 1 | 12 | 118 |
GO:0008201 | heparin binding | 5.77e-02 | 1.00e+00 | 4.078 | 1 | 1 | 122 |
GO:0007507 | heart development | 6.56e-02 | 1.00e+00 | 3.890 | 1 | 7 | 139 |
GO:0010628 | positive regulation of gene expression | 6.88e-02 | 1.00e+00 | 3.819 | 1 | 7 | 146 |
GO:0008022 | protein C-terminus binding | 7.56e-02 | 1.00e+00 | 3.678 | 1 | 8 | 161 |
GO:0000398 | mRNA splicing, via spliceosome | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 17 | 168 |
GO:0006355 | regulation of transcription, DNA-templated | 7.95e-02 | 1.00e+00 | 2.047 | 2 | 43 | 997 |
GO:0007049 | cell cycle | 8.15e-02 | 1.00e+00 | 3.566 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 8.19e-02 | 1.00e+00 | 3.558 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0019904 | protein domain specific binding | 8.37e-02 | 1.00e+00 | 3.525 | 1 | 8 | 179 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.60e-02 | 1.00e+00 | 3.485 | 1 | 22 | 184 |
GO:0004872 | receptor activity | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 8 | 189 |
GO:0008134 | transcription factor binding | 1.12e-01 | 1.00e+00 | 3.090 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 1.13e-01 | 1.00e+00 | 3.072 | 1 | 9 | 245 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 13 | 259 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 23 | 264 |
GO:0030198 | extracellular matrix organization | 1.30e-01 | 1.00e+00 | 2.864 | 1 | 6 | 283 |
GO:0007186 | G-protein coupled receptor signaling pathway | 1.32e-01 | 1.00e+00 | 2.834 | 1 | 1 | 289 |
GO:0003723 | RNA binding | 1.55e-01 | 1.00e+00 | 2.591 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.56e-01 | 1.00e+00 | 2.574 | 1 | 11 | 346 |
GO:0005925 | focal adhesion | 1.65e-01 | 1.00e+00 | 2.493 | 1 | 9 | 366 |
GO:0005730 | nucleolus | 1.85e-01 | 1.00e+00 | 1.328 | 2 | 66 | 1641 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.108 | 1 | 24 | 478 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.46e-01 | 1.00e+00 | 1.854 | 1 | 37 | 570 |
GO:0005737 | cytoplasm | 2.67e-01 | 1.00e+00 | 0.714 | 3 | 124 | 3767 |
GO:0005886 | plasma membrane | 3.65e-01 | 1.00e+00 | 0.674 | 2 | 49 | 2582 |
GO:0005739 | mitochondrion | 3.95e-01 | 1.00e+00 | 1.046 | 1 | 23 | 998 |
GO:0016021 | integral component of membrane | 6.45e-01 | 1.00e+00 | 0.056 | 1 | 17 | 1982 |
GO:0070062 | extracellular vesicular exosome | 7.20e-01 | 1.00e+00 | -0.220 | 1 | 57 | 2400 |
GO:0005829 | cytosol | 7.36e-01 | 1.00e+00 | -0.277 | 1 | 86 | 2496 |